Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine

25/06/2021
17/02/2026
EU PAS number:
EUPAS41623
Study
Ongoing

ENCePP Code of conduct

No
Data sources
Use of a Common Data Model (CDM)

CDM mapping

Yes

CDM Mappings

Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No